PHYTOMEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]

2024-05-07 ms8000001555903844 来自北京

偏重的研究方向：药理学;心血管
经验分享：请问submit to journal到with editor这一步大家都等了多久啊

9 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]

2024-05-15 ms8000002041881019 来自北京

偏重的研究方向：中药复方
经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们

9 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]

2024-04-17 ms8000001467150727 来自北京

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肾脏病;中药复方
经验分享：返修回去一个多月了，还是在邀请审稿人，难受

1 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]

2024-05-14 ms8000001555903844 来自北京

大家有遇到过一审换编辑的情况吗

10 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]

2024-01-17 14621ac1m87(暂无昵称) 来自江苏省

偏重的研究方向：中药;心血管
经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗

31 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]

2024-05-09 ms1000000847212667 来自新疆

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：单体;药理;胃肠疾病
经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。

7 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]

2024-05-11 ms1000000556586108 来自湖南省

请问各位老师这家接受非邀稿的综述吗？

7 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]

2024-03-01 ms2000002053337250 来自辽宁省

想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀

29 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]

2022-08-10 msyukira

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：中药药理;中药复方
经验分享：5.30投稿
5.31要求提供缩略词，补充后当晚提交了
6.6 under review
6.22 Required Reviews Completed
6.26 revise
主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生……
7.14 summit
7.15 Under Editor Assessment
7.24 under review
8.2 Required Reviews Completed
8.3 Decision in Process
8.4 accepted
8.6 Proof

感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下

66 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省)]

2024-04-15 ms6000000634273240 来自四川省

请问proof返回后大概多久online啊，已经大半个月了还没有online🥹

0 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务